Jennison Associates
MRK icon

Jennison Associates’s Merck MRK Stock Holding History

Jennison Associates’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-681,200
Closed -$34.3M – 645
2015
Q4 		$34.3M Hold
681,200
– – 0.03% 349
2015
Q3 		$32.1M Buy
+681,200
New +$36.2M 0.03% 371

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates's MRK Position: Q1 2026 in Review

Jennison Associates increased its Merck (MRK) stake by 12% in Q1 2026, buying an estimated $79.6M and bringing the position to 6,249,337 shares worth $752M. The position accounts for 0.52% of the portfolio, ranked #39.

Jennison Associates first reported a position in MRK in Q2 2013 and has held it in 43 quarters since. The position peaked at $1.32B in Q1 2014. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Jennison Associates held 6,249,337 shares of Merck worth $752M as of Q1 2026.
  • Jennison Associates bought 689,849 Merck shares in Q1 2026, an estimated $79.6M.
  • Merck made up 0.52% of Jennison Associates's portfolio in Q1 2026, its #39 holding.
  • Jennison Associates first reported a position in Merck in Q2 2013 and has held it in 43 quarters since.
  • Jennison Associates's Merck position peaked at $1.32B in Q1 2014.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Jennison Associates's 13F filing for Q1 2026, filed 6 May 2026.